FDA Finalizes Guidance on Postmarketing Safety Reporting for Combination Products

The GMP Letter
A A
The FDA has issued a final guidance on postmarketing safety reporting (PMSR) requirements for combination products.

To View This Article:

Login

Subscribe To The GMP Letter